Professional Documents
Culture Documents
Endophthalmitis Prophylaxis in Cataract Surgery PDF
Endophthalmitis Prophylaxis in Cataract Surgery PDF
Data on practice patterns for prophylaxis against infectious postoperative endophthalmitis (IPOE)
during cataract surgery in 9 European countries were searched in national registers and reviews of
published surveys. Summary reports assessed each nations IPOE rates, nonantibiotic prophylac-
tic routines, topical and intracameral antibiotic use, and coherence to the European Society of
Cataract & Refractive Surgeons (ESCRS) 2007 guidelines. Although the reliability and complete-
ness of available data vary between countries, the results show that IPOE rates differ significantly.
Asepsis routines with povidoneiodine and postoperative topical antibiotics are generally adopted.
Use of preoperative and perioperative topical antibiotics as well as intracameral cefuroxime varies
widely between and within countries. Five years after publication of the ESCRS guidelines, there is
no consensus on intracameral cefuroxime use. Major obstacles include legal barriers or persisting
controversy about the scientific rationale for systematic intracameral cefuroxime use in some
countries and, until recently, lack of a commercially available preparation.
Financial Disclosure: Dr. Pleyer has received research funding from Bundesministerium fur
Bildung und Forschung and Deutsche Forschungsgemeinschaft and has served as a consultant
for Abbott Medical Optics, Inc., Alcon Laboratories, Inc., Allergan, Inc., Bausch & Lomb, Novartis
Corp., Santen, Inc., Laboratoires Thea, and Ursapharm Arzneimittel GmbH. Dr. Tassignon has a pro-
prietary interest in the bag-in-the-lens technique and intraocular lenses licensed to Morcher GmbH.
No other author has a financial or proprietary interest in any material or method mentioned.
J Cataract Refract Surg 2013; 39:14211431 Q 2013 ASCRS and ESCRS
Cataract surgery is the most commonly performed Increasing resistance of Staphylococcus sp to a broad
surgical procedure in many developed countries,13 spectrum of antibiotics, including the latest fourth-
and the frequency continues to increase, probably generation fluoroquinolones, eg, methicillin-resistant
because of changes in population structure,4 technical S aureus (MRSA) and methicillin-resistant S epidermidis
advances with better outcomes, and an increasing pro- (MRSE), is currently a major concern.17,18 Fortunately,
portion of outpatient and second-eye procedures.5 IPOE is a rare complication. Reported IPOE frequency
Infectious postoperative endophthalmitis (IPOE) is varies widely, but a systematic review has shown an
the most dreaded complication of cataract surgery. overall estimate of 0.128% between 1963 and 2003.2
Infectious postoperative endophthalmitis has a devas- Despite the low incidence rate, IPOE generates a sub-
tating prognosis, with a visual outcome of 20/200 or stantial healthcare burden because of the high number
worse in 15% to 30% of cases.68 The severity and of procedures performed and the severe consequences
clinical course of IPOE depend on the virulence and of overt infections.
the number of inoculated pathogens, as well as the Various operative and nonoperative measures have
patient's immune state and the time of diagnosis and been advocated to prevent this serious complica-
treatment.9,10 The most common pathogens remain tion.19,20 Preoperative antisepsis of the periocular
gram-positive Staphylococcus epidermidis (or area with topical povidoneiodine is widely adopted
coagulase-negative staphylococci [CNS]) and S aureus and is considered the basic standard of IPOE preven-
(Table 1).6,1016 tion,21 although chlorhexidine is preferred in some
Sweden
Submitted: October 30, 2012.
Final revision submitted: January 24, 2013. Sweden has a long experience with intracameral
Accepted: January 26, 2013. cefuroxime-based antibiotic prophylaxis, which has already
been highlighted. The National Cataract Register was imple-
From the Department of Clinical Sciences/Ophthalmology mented in 1992 and now covers 100% of clinics and 98.5% of
(Behndig), Umea University Hospital, Umea, Sweden; Service procedures. Updated data covering more than 1 000 000
dOphtalmologie (Cochener), CHU Morvan, Brest, France; Autono- cataract surgeries were recently published.33 In 2010, 91 421
ma University of Barcelona (Guell), Barcelona, Spain; Hopital de la cataract surgery procedures were performed by 60 cataract
Croix-Rousse (Kodjikian), Lyon, France; Istituto de Clinica Oculisti- centers (43 public, 17 private). The IPOE rate is currently
less than 0.02,A whereas it was 0.1% in 1998 and 0.0595%
ca (Mencucci), Cattedra di Ottica Fisiopathologica, Florence, Italy;
during the 1999 to 2001 period.
Department of Ophthalmology (Nuijts), Academic Hospital Maas- Ordinary routines are followed in patient selection, hy-
tricht, Maastricht, The Netherlands; University-Eye Clinic (Pleyer), giene rules in the operating room, and eyedrop instillation.
Charite, CVK, Berlin, Germany; Oxford Eye Hospital (Rosen), Oxford, Antiseptic showers before surgery are not used. Ocular
United Kingdom; Department of Ophthalmology (Szaflik), Medical antisepsis is based on chlorhexidine. Use of intracameral
University of Warsaw, Warsaw, Poland; Faculty of Medicine and cefuroxime (1.0 mg/0.1 mL at the end of the procedure)
Health Science (Tassignon), University of Antwerp, Wilrijk, Belgium. started in 1999 and currently applies to about 90% of cataract
surgery procedures, but intracameral antibiotics are used
Author group meetings were supported by an unrestricted grant almost unanimously, with moxifloxacin as the preferred
from Laboratoires Thea, Clermont-Ferrand, France. option in a few centers. Cefuroxime is prepared in various
settings (local pharmacy, national pharmacy, or operating
Corresponding author: Anders Behndig, MD, PhD, Department of room). A combined antibiotic prophylaxis with cefuroxime
Clinical Sciences/Ophthalmology, Umea University Hospital, SE- and ampicillin is sometimes used in bilateral surgery or in
901 85 Umea, Sweden. E-mail: anders.behndig@ophthal.umu.se. patients with risk factors. Likewise, routine use of topical
Table 2. Summary findings on current antibiotic prophylaxis for cataract surgery in 9 European countries.
Number of IC Cefuroxime
Cataract IPOE Incidence Main Guidelines Prophylaxis Adoption
Surgeries Rate (Period)/ for Antibiotic Rates/Specific Factors Topical Antibiotic
Country per Year Origin of Source Data Prophylaxis Favoring or Limiting Use Prophylaxis
SwedenA 91 000 !0.04% (19922009) National Cataract 90% (2012) Not recommended
!0.02% (2012) Registry; and no routine use
Swedish Ophthalmological except RLE or high-
Society risk patients
National registry33 Omission of IC
(covering O98% antibiotics considered
of procedures)* unethical
FranceB,C 630 000 0,21%0.32% (19922002) National Agency for !5% (2006) Preoperative: 28%
0.03%0.06% (20072011) Health Products 40% (2011) (2007)36, currently
Safety (AFSSAPS)18 not recommended
National registry14 Recommended by Per-/post-operative:
(non-mandatory reporting); regulatory national 95%(2007)36, currently
limited surveys)12,34,32 guidelines since 201118 recommended
United O330 000 0.03%0.20% (19972006) Scottish Intercollegiate 10% (2005)23 Preoperative:
KingdomD Guidelines Network49; 45%-61% 6%-9% (2005)23
Royal College of (2009-2010)19,45,48
Ophthalmologists50
Multiple, often large Historically, the Per-/post-operative:
surveys7,13,19,20,23,37-45 subconjunctival route 90% (2005)23
was the preferred choice23
SpainE 200 000 0.48%/0.50% ESCRS guidelines10 Not known Preoperative:
0.056%/0.11% (1999-2008) variable15,31
ESCRS Z European Society of Cataract & Refractive Surgeons; IC Z intracameral; IPOE Z infectious postoperative endophthalmitis; RLE Z refractive lens exchange
Italics: yet unpublished, extrapolated or estimated figures
AK
Additional information from personal communications (2012) or from conference proceedings (see list in Other Cited Material).
*This figure may have included cases of toxic anterior segment syndrome.
antibiotics is uncommon, but fluoroquinolones may be used combined antibiotic plus steroid drops.36 A recent report
in refractive lens exchange and in high-risk patients. The rate from 2 large centers covering 3316 patients during a 2-year
of IPOE was lower from 1999 to 2009 than in 1998, and ana- period (January 2007 to December 2008) showed a 0.06%
lyses clearly showed that this was attributable to generalized IPOE rate after the implementation of systematic intracam-
intracameral cefuroxime use. eral cefuroxime injections.32 A recent survey showed that
There are no formal national guidelines, but there are the use of intracameral antibiotics (cefuroxime in 60% to
informal recommendations from the National Cataract 73% of cases) dramatically increased from 2006 to 2011
Registry and the Swedish Ophthalmological Society. (from 7% to 61%, respectively).C This trend is expected to
increase in future years because of the publication of the
national guidelines in 2011.
France
In France, national guidelines on intracameral cefuroxime United Kingdom
were recently released by the Health Ministry-governed Data on IPOE epidemiology and practice patterns in the
regulatory Agence Francaise de Securite Sanitaire des U.K. are fairly well known from the large series of reports
Produits de Sante,18 a unique feature among the 9 reviewed published over the past decade.7,13,19,20,23,3744 According
countries. About 630 000 cataract procedures are performed to a recent survey by the Royal National Institute of Blind
each year by 706 cataract centers (237 public hospitals, 469 People, the number of cataract operations reached 350 602
private clinics).B Endophthalmitis reporting to the national in 2010 but fell to 338 565 in 2011 because of cost-cutting
register (Observatoire National Des Endophtalmies)14 is measures.D The baseline IPOE rate reported in the British
not mandatory. Historical epidemiological studies have re- Ophthalmological Surveillance Unit study was 1/700 cata-
ported various incidence rates over timed0.32% in 1992,12 ract surgeries (0.14%); it was also estimated that only 62%
0.21% during the 2000 to 2002 period34d but the true current of IPOE cases were reported.7 A 2009 review by Carrim
rate is not known. et al.13 found that published IPOE rates during the 1997 to
Patients' infection risk assessments and antiseptic showers 2006 period (observed at single-unit, regional, or national
and shampoos (povidoneiodine the day before and the level) varied from 0.03% to 0.2%.7,13,3740
morning before surgery) are routinely performed. Recom- According to 4 surveys of ophthalmologists' practices,
mended antiseptic preparation of the operative site is based subconjunctival antibiotics, predominantly cefuroxime,
on povidoneiodine applied 3 times (10% on skin during were administered at the end of surgery in 68% to 82% of
dilation, 5% on skin and eye in the anesthesia room, 5% cases compared with intracameral antibiotics in only 10%
into conjunctival sac on the operating table). Moreover, anti- to 16% of cases.7,23,42,43 Some clinicians have argued that
sepsis duration should be timed with a stopwatch (2 minutes there is no evidence that a change from subconjunctival to
at each step). These measures must be associated with a intracameral cefuroxime would be more effective.45,46 Later
patient-selection process to identify infected and high-risk surveys have shown a strong shift toward the use of
patients, as well as hygiene measures in the operating room intracameral cefuroxime, with 44.7% to 61.0% of surgeons
applicable to staff, equipment, and the environment.18 preferring the intracameral administration route.19,44,47 A
Topical antibiotics are not recommended before cataract single-center retrospective analysis of 36 743 phacoemulsifi-
surgery. The national guidelines emphasize that because of cation procedures reported that intracameral cefuroxime
their high selective power, topical fluoroquinolones should was a safe alternative to subconjunctival cefuroxime with a
be reserved for curative treatment of severe eye infection.18 significantly lower rate of IPOE (subconjunctival versus in-
However, postoperative topical antibiotic prophylaxis is tracameral route: OR, 3.01; 95% CI, 1.37-6.63).20
recommended during 1 week and should target common Regarding practice guidelines, intracameral antibiotic
IPOE-causative bacteria, ie, gram-positive cocci.18,35 Cefur- prophylaxis is recommended for cataract surgery by the
oxime (1.0 mg/0.1 mL) intracameral injection at the end of Scottish Intercollegiate Guidelines Network48 whereas the
the procedure is a strongly recommended antibiotic prophy- Royal College of Ophthalmologists49 leaves the details of
laxis in the absence of any contraindication to cephalospo- antibiotic use to the surgeon's discretion.
rins.18 The drug is usually prepared by the center's local
pharmacy. Subconjunctival injections and antibiotic prophy-
Spain
laxis added to the irrigation fluid are not recommended.
When cephalosporin administration is contraindicated or There is no national register for cataract surgery or IPOE
in patients at risk, the national guidelines recommend oral in Spain, but some centers have developed their own local
levofloxacin (500 mg the day before and 500 mg on the day observational databases, allowing estimates of IPOE rates
of surgery). In general, at-risk patients are those with based on single-center samples: for instance, no cases of
diabetes mellitus, previous implantation of an intraocular IPOE were observed among the 1151 cataract surgery proce-
device other than for cataract surgery, and previous postop- dures performed in 2011 at Barcelona's Instituto de Micro-
erative endophthalmitis in the fellow eye; for cataract ciruga Ocular, with cefuroxime intracameral injections in
surgery only, cited risk factors are intracapsular extraction all cases.E About 200 000 cataract procedures are performed
and secondary implantation. In cases of capsule rupture each year.E
in patients who did not receive a preoperative systemic The following protocol, based on the ESCRS 2007 guide-
antibiotic, perioperative intravenous levofloxacin is lines, is used very commonly in private and public Spanish
recommended.18 institutions: preoperative prophylaxis combining lid hy-
According to a prospective longitudinal multicenter giene (scrubs with baby shampoo), topical antibiotics, and
observational study that enrolled 781 patients from povidoneiodine 10% solution applied on the skin before
September 2007 to February 2008 before the ESCRS study, the patient enters the operating room, then again before
28.5% of patients received preoperative topical antibiotic starting surgery (5-minute wait), combined with a povi-
prophylaxis and 94.7% received postoperative topical doneiodine 5% solution into the conjunctival sac. In case
national guidelines, Italian surgeons tend to follow the respected in the operating room. Topical antibiotics are
ESCRS 2007 recommendations, but the reference source is applied before, during, and after surgery. The drug of choice
mainly surgeon-dependent. is levofloxacin, and the administration schedule is 1 drop
twice daily the day before surgery, 1 drop before surgery,
The Netherlands 1 drop during and the night after surgery, 1 drop 4 times a
day for 2 weeks after surgery. In high-risk patients (blephar-
In the Netherlands, 140 000 cataract surgery procedures itis, complicated cases), the postoperative dosage is
are performed each year, 80% in general hospitals, 12% in ac- increased to 1 drop every 2 hours on the day of surgery.
ademic hospitals, and 8% within an increasing number of Although no hard data are available, intracameral antibi-
ambulatory surgery centers with multiple facilities.I otics are probably not injected in most procedures because of
Outcome registration is mandatory for all surgeons, as re- off-label use and complex preparation.K However, cefurox-
quested by the Dutch Ophthalmological Society and the ime (1.0 mg/0.1 mL) has been used in 100% of the proce-
Netherlands IntraOcular Implant Club. According to these dures in the Warsaw center since 2005; until 2012, the
databases, the IPOE rate is 0.03%.J preparation was outsourced to a commercial pharmacy,
Povidoneiodine eyedrops in a concentration varying but currently syringes are prepared in the operating room.
from 0.3% to 5.0% are instilled preoperatively (0.3% is avail- Specific national guidelines have been prepared and are
able as a commercial preparation for topical use), and then now in the process of being approved. The Polish Society
povidoneiodine 5% to 10% is applied on the skin and of Ophthalmologists' recommendations are similar to the
diluted solution (dilution according to surgeon's preference) ESCRS 2007 guidelines.
on the ocular surface for 0.5 to 3.0 min. Class 1 hygiene rules
are applied to the operating room.53 Topical antibiotics are
often used before, during, and after the procedure; adminis-
trations and dosages vary. Use of intracameral antibiotics
started in 2007 after the publication of the ESCRS 2007 guide- DISCUSSION
lines and was used in approximately 27% of procedures in We found that the current practice patterns for IPOE
2010.J Syringes are prepared at the hospital's pharmacy. prophylaxis between European countries differ signi-
In the absence of specific guidelines from national health
authorities and on the basis of the low endophthalmitis
ficantly and often diverge from the antibiotic prophy-
rate of 0.03% in the Netherlands, the Dutch Ophthalmolog- laxis practices recommended by the ESCRS guidelines.
ical Society recommends cefuroxime in high-risk cases only The data reported in the present overview come from
(capsule breaks, clear cornea incisions). Systematic use is heterogeneous sources: Swedish data are based on a
considered debatable. national register with a high coverage; Dutch IPOE
A retrospective review of all consecutive patients treated
for acute IPOE after cataract surgery (N Z 250) in a single
rates are based on a mandatory outcome reporting
center from 1996 to 2006 was recently published.16 Bacterial and practice trends; IPOE rates in the U.K. were
cultures (250 cases) showed bacterial growth in 66.4% of described by a series of dedicated surveys; in some
cases. Of these, 53.6% revealed gram-positive CNS, 38.0% other countries, data about the volume of cataract sur-
other gram-positive bacteria, 6.0% gram-negative patho- geries, IPOE prophylaxis practice patterns, and IPOE
gens, and 2.4% polymicrobial cultures.
incidence rates are more or less unknown because an
adequate national epidemiological system does not
Poland
exist. Between these extremes, a variable amount of
According to the national health insurance refunding sys- reliable data documents exists in the remaining
tem, 152 000 cataract surgery procedures were performed in countries.
Poland in 2011. About 15 000 to 20 000 additional cataract
surgeries are performed in private practices, although their While acknowledging that the variability of source
exact number is not known.K No reliable data on current data limits our study's value, we believe that this lim-
IPOE incidence rates are available. A survey published in itation is not specific to this review but rather reflects
2004 assessed data from 53 ophthalmology centers in the lack of adequate epidemiologic tools and system-
Poland, involving 28 674 cases of routine cataract surgery, atic reporting in most countries. In addition, this over-
6518 cases of complicated cataract surgery, 1387 cases of
combined cataract and glaucoma surgery, and 2978 cases view can by no means determine whether differences
of glaucoma surgery. The prevalence of IPOE in this group in practice patterns and hygiene routines are reflected
of patients ranged from 0.29% after cataract surgery to in the varying IPOE rates. One also has to consider a
0.93% after complex surgery (cataract and glaucoma).54 possible bias since centers participating in surveys or
These high incidence rates were interpreted as possible selec- reporting systems may be more attentive to all steps
tion bias due to the small size of the study sample. In addi-
tion, IPOE was not proven by culture or polymerase chain in the processes of patient preparation and surgical
reaction so some cases of toxic anterior segment syndrome procedures. Thus, the present overview does not pre-
might have been included. tend to report actual practice patterns and epidemio-
In the absence of an accurate national observational data- logical facts in the reviewed countries or to provide
base, the following information applies to the protocol used answers to why the IPOE rates differ, but it probably
in a single center in Warsaw onlyK: Prophylactic measures
include patient selection, antiseptic showers before surgery, offers a fair picture of the current status in this field.
and systematic povidoneiodine 5% antisepsis on the ocular It also helps to explain why the ESCRS guidelines
surface for 1 to 3 min. Routine sterile environment is are not yet consistently adopted in these countries.
Practice patterns for general hygiene rules in the guidelines do not recommend it.18 Subconjunctival
operating room and systematic preoperative antisep- antibiotic prophylaxis has also been used over the
sis with povidoneiodine or chlorhexidine tend to past 30 years, particularly in the U.K. However, on
converge. The use of preoperative antisepsis with po- the basis of available data, the ESCRS guidelines stated
vidoneiodine (5% solution on the conjunctiva and that it probably has little prophylactic effect on the pre-
cornea and 5% to 10% solution on the periorbital vention of IPOE9,10,21 and the French 2011 guidelines
area for R3 min) is based on a microbiological and do not recommend its use.18
clinical rationale since it has been shown to diminish Intracameral cefuroxime is recommended by ESCRS
the bacterial load and prevent IPOE.21,25,5558 Its use and French guidelines,11,13 by the Scottish Intercolle-
is recommended by current guidelines.10,17,18 If povi- giate Guidelines Network,48 and by Canadian guide-
doneiodine is contraindicated, chlorhexidine 0.05% lines,63 while details of antibiotic use are left to the
is an alternative.10,18,59 The use of chlorhexidine as a individual surgeon's discretion by the Royal College
primary antisepsis agent in Sweden has proven effi- of Ophthalmologists49 and the American Academy
cient and safe over a long period.33,60 of Ophthalmology.17
Regarding antibiotic prophylaxis regimens, data of Ophthalmologists tend to follow the ESCRS recom-
landmark importance came out of the ESCRS random- mendations for intracameral cefuroxime in many
ized trial, which comprised 16 603 patients and European countries lacking national guidelines, but
compared (1) intracameral cefuroxime (1.0 mg/0.1 mL) legal barriers may oppose its use. Controversy about
bolus injections at the end of cataract surgery with the scientific rationale for systematic intracameral
no intracameral cefuroxime and (2) topical periopera- cefuroxime persists in the U.K., where the subconjunc-
tive levofloxacin 0.5% eyedrops with no perioperative tival route has been historically dominant and in the
topical levofloxacin. Topical levofloxacin was given in Netherlands where its use is limited to high-risk
all groups postoperatively. The results showed a patients. Generally, persisting controversies about
nearly 5-fold decrease in the risk for presumed and the scientific rationale for systematic use, legal bar-
proven IPOE when intracameral cefuroxime was riers, and the lack of a commercially available prepara-
included.4 The effect of topical perioperative levoflox- tion appear to have conferred major practical barriers
acin was not significant. The incidence rates were to intracameral cefuroxime's widespread use,18,44,64
0.345% for total IPOE and 0.247% for proven IPOE in although a commercially available product is
the group with placebo drops and no intracameral ce- currently being introduced.
furoxime, which may be regarded as the true current Cefuroxime is a second-generation cephalosporin
background rates of IPOE after phacoemulsification that is effective against most bacteria that cause
in Europe in the absence of antibiotic prophylaxis.4 IPOE,26 in particular staphylococci and streptococci
Our overview shows that postoperative topical anti- (except MRSA, MRSE, and Enterococcus faecalis). It is
biotic prophylaxis is also commonly used in all coun- also effective against gram-negative bacteria (except
tries (except Sweden), particularly in clear corneal Pseudomonas aeruginosa) and P acnes. Bactericidal ce-
incision surgery, for up to 2 weeks.10,18 Its efficacy, furoxime concentrations of 2742 mg/L are achieved
however, is not proven or only weakly proven by within 30 seconds of intracameral injection and drops
retrospective studies.61,62 In the ESCRS study, levo- to 756 mg/L 1 hour later.27 This was the rationale for
floxacin was administered to all groups postopera- establishing the administration regimen still in use
tively. According to the authors, the relatively high (1.0 mg/0.1 mL at the end of phacoemulsification cata-
incidence rates of IPOE in subgroups without intra- ract surgery before the wound is closed), which started
cameral cefuroxime suggested that postoperative lev- in Sweden 13 years ago.2730,33 The regimen has been
ofloxacin alone conferred little benefit. An alternative further supported by the ESCRS randomized trial re-
explanation is that had this type of antibiotic prophy- sults4 and additional retrospective studies in France,
laxis not been used, the rates across all groups would Spain, and the U.K.20,24,31,32 Intracameral cefuroxime
have been higher.4 has been shown to have a good safety profile, with
Much wider variation in preoperative and perioper- no evidence of increased endothelial cell loss or any
ative topical antibiotic prophylaxis regimens, as well proof of increased bloodaqueous barrier distur-
as intracameral cefuroxime, is observed in this bance.28 The main disadvantage with cefuroxime
overview. The ESCRS study has not assessed the role may instead be the gaps in its antimicrobial spectrum.
of preoperative topical antibiotic prophylaxis. A previ- Notably, there is a striking convergence between the
ous systematic review concluded that its efficacy was very low IPOE rate in Sweden (!0.040%; 1992
not yet scientifically proven.21 Thus, the ESCRS 2007 2009),33 where intracameral cefuroxime is used in
guidelines cite preoperative topical antibiotic prophy- 90% of cases, mostly without topical antibiotic pro-
laxis as an option to consider,10 while the French 2011 phylaxis, and the equally low rate reported in the
Netherlands (0.03%),J where topical antibiotics are the of healthcare-associated infections.48 The first line of
basis of IPOE prophylaxis while intracameral cefurox- prevention must always be general hygiene and asep-
ime is used in only 27% of cases. sis measures, which encompass patient selection, hy-
Considering the significant differences in IPOE rates giene rules in the operating room, and surgical site
seen in scientific reports (including the ESCRS antisepsis. As stated by the Scottish Intercollegiate
randomized trial), it may appear a bit surprising that Guidelines Network, antibiotics may then be used in
intracameral cefuroxime is still far from being consis- a manner that is supported by evidence of effective-
tently adopted by European ophthalmologists either ness, minimizing the effects on the patient's normal
systematically or in targeted cases (ie, high-risk bacterial flora and causing minimal change to the
patients). However, it should be noticed that the patient's host defenses.48 To prevent resistance devel-
comparative evidence base is incomplete; for instance, opment, guidelines have recommended limiting the
the ESCRS trial did not answer many relevant ques- prescription of oral fluoroquinolones to high-risk pa-
tions such as the relative efficacy of intracameral cefur- tients (eg, severe atopic dermatitis).10,76
oxime compared with a full course of preoperative, Pathogens found in proven IPOE cases mostly orig-
perioperative, and postoperative topical antibiotics; inate from the eye-surrounding flora,56 and the micro-
subconjunctival injections; or antibiotics in irrigation bial spectrum is dominated by gram-positive
fluid. Although a systematic comparison of all staphylococci and streptococci. Intraocular contami-
possible options in large randomized trials is not nation by the facultative pathogenic surrounding flora
feasible, it may explain why these ophthalmologists has been shown to occur in a high proportion of the
remain unconvinced that they should have changed procedures.10,7784 Still, the development of a true
their practices. IPOE is rare. In the ESCRS study, 5 significant risk
It has been suggested that topical fourth-generation factors for IPOE development were identified: clear
fluoroquinolones such as moxifloxacin and gatifloxa- corneal incisions versus scleral tunnel, surgical com-
cin would be preferable to intracameral cefuroxime, plications, silicone versus acrylic intraocular lenses
among other things because of their broader spectrum (IOLs), less experienced surgeon versus more experi-
of activity.61,6567 Fourth-generation fluoroquinolones enced surgeon, and no use of intracameral cefurox-
were the most frequent topical antibiotic prophylaxis ime.4 Notably, factors such as the use of an IOL
used by the American Society of Cataract and Refrac- injector, immunosuppression, diabetes mellitus, and
tive Surgery survey respondents in 2007,64 and their the use of perioperative topical levofloxacin did not
efficacy and safety are further supported by a retro- affect the IPOE rate significantly in the ESCRS study.4
spective study involving 29 276 cataract surgeries.68 It should be emphasized, however, that the literature
Other studies have also reported that intracameral regarding many of these IPOE risk factors is contradic-
moxifloxacin is safe for IPOE prophylaxis.69,70 The tory. Although some risk factors (such as capsule
ESCRS guidelines, on the other hand, state that the rupture and vitreous loss) are undisputable, the occur-
use of topical fourth-generation fluoroquinolones, rence of an IPOE is very difficult to predict, which em-
similar to that of intracameral vancomycin, raises phasizes the importance of an effective prophylactic
ethical questions about the use of reserve antibiotics strategy in routine practice.
for prophylaxis, as opposed to treatment of estab- In conclusion, intracameral cefuroxime reduces the
lished IPOE,10 and the French guidelines state that risk for IPOE after cataract surgery, as shown by the
topical fluoroquinolones are reserved for curative ESCRS study and multiple retrospective European
treatment of severe eye infections.18 studies, and is recommended by the ESCRS and the
Managing patients with contraindications for cefur- national guidelines in France.
oxime is a rare issue. Anaphylactic hypersensitivity re- Five years have passed since the publication of the
actions, occurring a few minutes after intracameral ESCRS study, but the IPOE prophylaxis routines,
cefuroxime injection, have been reported27,7173 but including the use of intracameral cefuroxime, still
are extremely rare, the risk being estimated at vary widely between European countries. There is a
0.0001% to 0.1%.19,74,75 In patients with a known al- convergence in antisepsis routines with povidone
lergy to cephalosporins, cefuroxime is not recommen- iodine and in the use of postoperative topical antibi-
ded.10,18 Suggested alternatives are intracameral otics (despite the findings of the ESCRS study), with
injection of vancomycin with intensive topical quino- few exceptions. On the contrary, the use of preopera-
lones (eg, levofloxacin, which may be a useful adjunct tive and intraoperative topical antibiotics and the use
for coverage of gram-negative bacteria)10 or preopera- of intracameral or subconjunctival antibiotics differ
tive oral levofloxacin.18 significantly between, and also within, countries.
Antibiotic prophylaxis should be regarded as one Controversies about the scientific rationale for intra-
component of a global effective strategy for the control cameral cefuroxime use in some countries, legal
barriers, and the lack of a commercially available prep- 13. Carrim ZI, Richardson J, Wykes WN. Incidence and visual
aration appeared to be the major obstacles to system- outcome of acute endophthalmitis after cataract surgerydthe
experience of an eye department in Scotland. Br J Ophthalmol
atic application of this routine. 2009; 93:721725
14. Kodjikian L, Salvanet-Bouccara A, Grillon S, Forestier F,
REFERENCES Seegmuller JL, Berdeaux G; the French Collaborative Study
1. Tan CS, Wong HK, Yang FP. Epidemiology of postoperative Group on Endophthalmitis. Postcataract acute endophthalmitis
endophthalmitis in an Asian population: 11-year incidence and in France: national prospective survey. J Cataract Refract Surg
effect of intracameral antibiotic agents. J Cataract Refract Surg 2009; 35:8997
2012; 38:425430 15. Garca-Sa enz MC, Arias-Puente A, Rodrguez-Caravaca G,
2. Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Andre s Alba Y, Ban
~uelos Ban~uelos J. Endoftalmitis tras ciruga
Sweet PM, McDonnell PJ. Acute endophthalmitis following de cataratas: epidemiologa, aspectos clnicos y profilaxis anti-
cataract surgery: a systematic review of the literature. Arch biotica [Endophthalmitis after cataract surgery: epidemiology,
Ophthalmol 2005; 123:613620. Available at: http://archopht. clinical features and antibiotic prophylaxis]. Arch Soc Esp Of-
jamanetwork.com/data/Journals/OPHTH/9940/ecs40117.pdf. talmol 2010; 85:263267. Available at: http://scielo.isciii.es/
Accessed March 7, 2013 pdf/aseo/v85n8/original1.pdf. Accessed March 7, 2013
3. West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. 16. Pijl BJ, Theelen T, Tilanus MAD, Rentenaar R, Crama N. Acute
The incidence of endophthalmitis after cataract surgery among endophthalmitis after cataract surgery: 250 consecutive cases
the U.S. Medicare population increased between 1994 and treated at a tertiary referral center in the Netherlands. Am J
2001. Ophthalmology 2005; 112:13881394. Available at: Ophthalmol 2010; 149:482487
http://www.v2020la.org/pub/PUBLICATIONS_BY_TOPICS/ 17. American Academy of Ophthalmology. Cataract in the Adult
Endophthalmitis/Rate%20of%20endophthamitis%20(ready). Eye; Preferred Practice Patterns. San Francisco, CA, Amer-
pdf. Accessed March 7, 2013 ican Academy of Ophthalmology, 2011. Available at: http://
4. ESCRS Endophthalmitis Study Group. Prophylaxis of postop- one.aao.org/CE/PracticeGuidelines/PPP_Content.aspx?cidZ
erative endophthalmitis following cataract surgery: results of a80a87ce-9042-4677-85d7-4b876deed276. Accessed March
the ESCRS multicenter study and identification of risk factors. 5, 2013
J Cataract Refract Surg 2007; 33:978988 18. Agence Francaise de Se curite
Sanitaire des Produits de Sante .
5. Lundstro m M, Barry P, Henry Y, Rosen P, Stenevi U. Evidence- Antibioprophylaxie en Chirurgie Oculaire. Saint-Denis, France,
based guidelines for cataract surgery: guidelines based on data Argumentaire, 2011. Available at: http://nosobase.chu-lyon.fr/
in the European Registry of Quality Outcomes for Cataract and recommandations/afssaps/2011_Antibioprophylaxie-chirurgie
Refractive Surgery database. J Cataract Refract Surg 2012; Oculaire_Argu_AFSSAPS.pdf. Accessed March 7, 2013
38:10861093 19. Nanavaty MA, Wearne MJ. Perioperative antibiotic prophylaxis
6. Endophthalmitis Vitrectomy Study Group. Results of the during phaco-emulsification and intraocular lens implantation:
Endophthalmitis Vitrectomy Study; a randomized trial of immedi- national survey of smaller eye units in England. Clin Exp Oph-
ate vitrectomy and of intravenous antibiotics for the treatment of thalmol 2010; 38:462466
postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 20. Yu-Wai-Man P, Morgan SJ, Hildreth AJ, Steel DH, Allen D. Ef-
113:14791496 ficacy of intracameral and subconjunctival cefuroxime in pre-
7. Kamalarajah S, Silvestri G, Sharma N, Khan A, Foot B, Ling R, venting endophthalmitis after cataract surgery. J Cataract
Cran G, Best R. Surveillance of endophthalmitis following cata- Refract Surg 2008; 34:447451
ract surgery in the UK. Eye 2004; 18:580587. Available at: 21. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis pro-
http://www.nature.com/eye/journal/v18/n6/pdf/6700645a.pdf. phylaxis for cataract surgery; an evidence-based update.
Accessed March 7, 2013 Ophthalmology 2002; 109:1324
8. Kernt M, Kampik A. Endophthalmitis: pathogenesis, clinical pre- 22. Liesegang TJ. Perioperative antibiotic prophylaxis in cataract
sentation, management, and perspectives. Clin Ophthalmol surgery. Cornea 1999; 18:383402; erratum 2000; 19:123
2010; 4:121135. Available at: http://www.ncbi.nlm.nih.gov/ 23. Gordon-Bennett P, Karas A, Flanagan D, Stephenson C,
pmc/articles/PMC2850824/pdf/opth-4-121.pdf. Accessed March Hingorani M. A survey of measures used for the prevention
7, 2013 of postoperative endophthalmitis after cataract surgery in the
9. Peyman GA, Lee PJ, Seal DV. Endophthalmitis; Diagnosis and United Kingdom. Eye 2008; 22:620627. Available at: http://
Management. London, UK, Taylor & Francis, 2004 www.nature.com/eye/journal/v22/n5/pdf/6702675a.pdf. Ac-
10. Barry P, Behrens-Baumann W, Pleyer U, Seal D, eds. ESCRS cessed March 7, 2013
Guidelines on Prevention, Investigation and Management of 24. Garca-Sa enz MC, Arias-Puente A, Rodrguez-Caravaca G,
Post-Operative Endophthalmitis. The European Society for Ban ~ uelos JB. Effectiveness of intracameral cefuroxime in pre-
Cataract & Refractive Surgeons, 2007. Available at: http:// venting endophthalmitis after cataract surgery; ten-year
www.escrs.org/vienna2011/programme/handouts/IC-100/IC- comparative study. J Cataract Refract Surg 2010; 36:203207
100_Barry_Handout.pdf. Accessed March 7, 2013 25. Schmitz S, Dick HB, Krummenauer F, Pfeiffer N. Endophthal-
11. Fisch A, Salvanet A, Prazuck T, Forester F, Gerbaud L, mitis in cataract surgery; results of a German survey. Ophthal-
Coscas G, Lafaix C; the French Collaborative Study Group mology 1999; 106:18691877
on Endophthalmitis. Epidemiology of infective endophthalmitis 26. Seal DV, Barry P, Gettinby G, Lees F, Peterson M, Revie CW,
in France. Lancet 1991; 338:13731376 Wilhelmus KR; for the ESCRS Endophthalmitis Study Group.
12. Salvanet-Bouccara A, Forestier F, Coscas G, Adenis JP, ESCRS study of prophylaxis of postoperative endophthalmitis
Denis F. Endophtalmies bacte riennes. Resultats ophtalmologi- after cataract surgery; case for a European multicenter study.
ques dune enque ^te prospective multicentrique nationale J Cataract Refract Surg 2006; 32:396406
[Bacterial endophthalmitis. Ophthalmological results of a na- 27. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intra-
tional multicenter prospective survey]. J Fr Ophtalmol 1992; cameral cefuroxime; efficacy in preventing endophthalmitis after
15:669678 cataract surgery. J Cataract Refract Surg 2002; 28:977981
28. Montan PG, Wejde G, Setterquist H, Rylander M, PMC1955623/pdf/731.pdf. Accessed March 7, 2013. Correc-
Zetterstro m C. Prophylactic intracameral cefuroxime; evalua- tion to Table 2 available at: http://bjo.bmj.com/content/suppl/
tion of safety and kinetics in cataract surgery. J Cataract 2007/05/30/bjo.2006.104216.DC1/916731webonlyfig.pdf. Ac-
Refract Surg 2002; 28:982987 cessed March 7, 2013
29. Lundstro m M, Wejde G, Stenevi U, Thorburn W, Montan P. En- 41. Dinakaran S, Crome DA. Prophylactic measures prevalent
dophthalmitis after cataract surgery; a nationwide prospective in the United Kingdom. J Cataract Refract Surg 2002; 28:
study evaluating incidence in relation to incision type and loca- 387388
tion. Ophthalmology 2007; 114:866870 42. Gupta MS, McKee HD, Stewart OG. Perioperative prophylaxis
30. Wejde G, Samolov B, Seregard S, Koranyi G, Montan PG. Risk for cataract surgery: survey of ophthalmologists in the north of
factors for endophthalmitis following cataract surgery: a retro- England. J Cataract Refract Surg 2004; 30:20212022
spective case-control study. J Hosp Infect 2005; 61:251256 43. Ang GS, Barras CW. Prophylaxis against infection in cataract
31. Dez MR, de la Rosa G, Pascual R, Giro n C, Arteta M. Profilaxis surgery: a survey of routine practice. Eur J Ophthalmol 2006;
de la endoftalmitis postquiru rgia con cefuroxima intracameru- 16:394400
lar: experiencia de cincos an ~ os [Prophylaxis of postoperative 44. Gore DM, Angunawela RI, Little BC. United Kingdom survey of
endophthalmitis with intracameral cefuroxime: a five years antibiotic prophylaxis practice after publication of the ESCRS
experience]. Arch Soc Esp Oftalmol 2009; 84:8590. Available Endophthalmitis Study. J Cataract Refract Surg 2009;
at: http://scielo.isciii.es/pdf/aseo/v84n2/original2.pdf. Ac- 35:770773
cessed March 7, 2013 45. Schein OD. Prevention of endophthalmitis after cataract sur-
32. Gualino V, San S, Guillot E, Korobelnik J-F, Colin J, Trout H, gery: making the most of the evidence [editorial]. Ophthal-
Massin P, Gaudric A, Tadayoni R. Injections intracame rulaire mology 2007; 114:831832; erratum, 1088
de ce furoxime dans la prophylaxie des endophtalmies apre s 46. Spokes DM, Walters G. Prophylaxis of postoperative endoph-
chirurgie de cataracte: organisation et re sultats. Intracameral thalmitis [letter]. J Cataract Refract Surg 2007; 33:561; reply by
cefuroxime injections in prophylaxis of postoperative endoph- P Barry, 561
thalmitis after cataract surgery: implementation and results. 47. Murjaneh S, Waqar S, Hale JE, Kasmiya M, Jacob J,
J Fr Ophtalmol 2010; 33:551555 Quinn AG. National survey of the use of intraoperative antibi-
33. Behndig A, Montan P, Stenevi U, Kugelberg M, Lundstro m M. otics for prophylaxis against postoperative endophthalmitis
One million cataract surgeries: Swedish National Cataract following cataract surgery in the UK [letter]. Br J Ophthalmol
Register 19922009. J Cataract Refract Surg 2011; 2010; 94:14101411
37:15391545 48. Scottish Intercollegiate Guidelines Network. Antibiotic prophy-
34. Morel C, Gendron G, Tosetti D, Poisson F, Chaumeil C, laxis in surgery; a national clinical guideline. Edinburgh, Scot-
Auclin F, Laplace O, Tuil E, Warnet J- M. Infections nosoco- land, 2008. Available at: http://www.sign.ac.uk/pdf/sign104.
miales endoculaires au CHNO des XV-XX de 2000 a 2002 pdf. Accessed March 7, 2013
[Postoperative endophthalmitis: 2000 2002 results in the 49. Royal College of Ophthalmologists. The Royal College of Oph-
XV-XX national ophthalmologic hospital]. J Fr Ophtalmol thalmologists. London, UK, Cataract Surgery Guidelines,
2005; 28:151156. Available at: http://www.em-consulte.com/ 2010; Available at: http://www.rcophth.ac.uk/core/core_
showarticlefile/112962/index.pdf. March 7, 2013 picker/download.asp?idZ544&filetitleZCataractCSurgeryC
35. Cochereau I, Korobelnik J-F, Robert P-Y, Hajjar J. Antibiopro- GuidelinesC2010. Accessed March 7, 2013
phylaxie en chirurgie ophtalmologique. A propos des recom- 50. Krummenauer F, Kurz S, Dick HB. Epidemiological evaluation
mandations de lAFSSAPS [Antibioprophylaxis in ocular of intraoperative antibiosis as a protective agent against en-
surgery: AFSSAPS recommendations]. J Fr Ophtalmol 2011; dophthalmitis after cataract surgery. Pharmacoepidemiol
34:428430 Drug Saf 2006; 15:662666
36. Colin J, El Kebir S, Eydoux E, Hoang-Xuan T, Rozot P, 51. Ness T, Kern WV, Frank U, Reinhard T. Postoperative nosoco-
Weiser M. Assessment of patient satisfaction with outcomes mial endophthalmitis: is perioperative antibiotic prophylaxis
of and ophthalmic care for cataract surgery. J Cataract advisable? A single centres experience. J Hosp Infect 2011;
Refract Surg 2010; 36:13731379 78:138142
37. Desai P, Reidy A, Minassian DC. Profile of patients presenting 52. Caporossi A, Martone G, Paradiso A, Bizzarri B, Cartocci G. Ri-
for cataract surgery in the UK: national data collection. Br J sultati di una survey italiana sulle procedure di sterilizzazione
Ophthalmol 1999; 83:893896. Available at: http://bjo.bmj. nella chirurgia della cataratta. La Voce AICCER 2011; 1:14
com/content/83/8/893.full.pdf. Accessed March 7, 2013 19. Available at: http://www.aiccer.it/riviste/LaVoce1-48.pdf.
38. Mayer E, Cadman D, Ewings P, Twomey JM, Gray RH, Accessed March 7, 2013
Claridge KG, Hakin KN, Bates AK. A 10 year retrospective sur- 53. Charkowska A. Ensuring cleanliness in operating theatres. Int J
vey of cataract surgery and endophthalmitis in a single eye unit: Occup Saf Ergon 2008; 14:447453. Available at: http://www.
injectable lenses lower the incidence of endophthalmitis. Br J ciop.pl/27986. Accessed March 7, 2013
Ophthalmol 2003; 87:867869. Available at: http://www.ncbi. 54. Szaflik J, Zaras M. [The use of antibiotics during the perioper-
nlm.nih.gov/pmc/articles/PMC1771777/pdf/bjo08700867.pdf. ative period and incidence of complicationsbased on data
Accessed March 7, 2013 from selected ocular surgery centers in Poland]. [Polish] Klin
39. Mollan SP, Gao A, Lockwood A, Durrani OM, Butler L. Postca- Oczna 2004; 106:521524
taract endophthalmitis: incidence and microbial isolates in a 55. Isenberg SJ, Apt L, Yoshimori R, Pham C, Lam NK. Efficacy of
United Kingdom region from 1996 through 2004. J Cataract topical povidone-iodine during the first week after ophthalmic
Refract Surg 2007; 33:265268; erratum, 759 surgery. Am J Ophthalmol 1997; 124:3135
40. Zaidi FH, Corbett MC, Burton BJ, Bloom PA. Raising the 56. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with
benchmark for the 21st centurydthe 1000 cataract operations topical povidone-iodine. Ophthalmology 1991; 98:17691775
audit and survey: outcomes, consultant-supervised training 57. Bohigian GM. A study of the incidence of culture-positive
and sourcing NHS choice. Br J Ophthalmol 2007; 91:731 endophthalmitis after cataract surgery in an ambulatory care
736. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/ center. Ophthalmic Surg Lasers 1999; 30:295298
58. Carrim ZI, Mackie G, Gallacher G, Wykes WN. The efficacy of 74. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001;
5% povidone-iodine for 3 minutes prior to cataract surgery. Eur 345:804809
J Ophthalmol 2009; 19:560564 75. Anne S, Reisman RE. Risk of administering cephalosporin
59. Kramer A, Rudolph P. Efficacy and tolerance of selected anti- antibiotics to patients with histories of penicillin allergy. Ann
septic substances in respect of suitability for use on the eye. Allergy Asthma Immunol 1995; 74:167170
Dev Ophthalmol 2002; 33:117144 76. Tuft SJ, Ramakrishnan M, Seal DV, Kemeny DM, Buckley RJ.
60. Montan PG, Setterquist H, Marcusson E, Rylander M, Role of Staphylococcus aureus in chronic allergic conjuncti-
Ransjo U. Preoperative gentamicin eye drops and chlorhexi- vitis. Ophthalmology 1992; 99:180184
dine solution in cataract surgery. Experimental and clinical 77. Sherwood DR, Rich WJ, Jacob JS, Hart RJ, Fairchild YL. Bac-
results. Eur J Ophthalmol 2000; 10:286292 terial contamination of intraocular and extraocular fluids during
61. Jensen MK, Fiscella RG, Crandall AS, Moshirfar M, Mooney B, extracapsular cataract extraction. Eye 1989; 3:308312.
Wallin T, Olson RJ. A retrospective study of endophtalmitis rates Available at: http://www.nature.com/eye/journal/v3/n3/pdf/eye
comparing quinolone antibiotics. Am J Ophthalmol 2005; 139: 198944a.pdf. Accessed March 7, 2013
141148 78. Dickey JB, Thompson KD, Jay WM. Anterior chamber aspirate
62. Thoms SS, Musch DC, Soong HK. Postoperative endophthal- cultures after uncomplicated cataract surgery. Am J Ophthal-
mitis associated with sutured versus unsutured clear corneal mol 1991; 112:278282
cataract incisions. Br J Ophthalmol 2007; 91:728730. Avail- 79. Montan PG, Koranyi G, Setterquist HE, Stridh A, Philipson BT,
able at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC19556 Wiklund K. Endophthalmitis after cataract surgery: risk factors
19/pdf/728.pdf. Accessed March 7, 2013 relating to technique and events of the operation and patient
63. Canadian Agency for Drugs and Technologies in Health. history; a retrospective case-control study. Ophthalmology
Intracameral Antibiotics for the Prevention of Endophthalmitis 1998; 105:21712177
Post-Cataract Surgery: Clinical Effectiveness, Cost- 80. Leong JK, Shah R, McCluskey PJ, Benn RA, Taylor RF. Bac-
Effectiveness and Guidelines, 20 March 2012. Available at: terial contamination of the anterior chamber during phacoemul-
http://www.cadth.ca/media/pdf/htis/mar-2012/RB0480%20 sification cataract surgery. J Cataract Refract Surg 2002;
IntracameralAntibiotics%20Final.pdf. Accessed March 7, 2013 28:826833
64. Chang DF, Braga-Mele R, Mamalis N, Masket S, Miller KM, 81. Srinivasan R, Tiroumal S, Kanungo R, Natarajan MK. Microbial
Nichamin LD, Packard RB, Packer M; for the ASCRS Cataract contamination of the anterior chamber during phacoemulsifica-
Clinical Committee. Prophylaxis of postoperative endophthal- tion. J Cataract Refract Surg 2002; 28:21732176
mitis after cataract surgery; results of the 2007 ASCRS mem- 82. Feys J, Emond J-P, Salvanet-Bouccara A, Dublanchet A.
ber survey. J Cataract Refract Surg 2007; 33:18011805 e
Epid miologie de la contamination bacte rienne oculaire en
65. OBrien TP, Arshinoff SA, Mah FS. Perspectives on antibiotics chirurgie de la cataracte [Bacterial contamination; epidemi-
for postoperative endophthalmitis prophylaxis: potential role of ology in cataract surgery]. J Fr Ophtalmol 2003; 26:255258
moxifloxacin. J Cataract Refract Surg 2007; 33:17901800 83. Mistlberger A, Ruckhofer J, Raithel E, Mu ller M, Alzner E,
66. Scoper SV. Review of third- and fourth-generation fluoroquino- Egger SF, Grabner G. Anterior chamber contamination during
lones in ophthalmology: in-vitro and in-vivo efficacy. Adv Ther cataract surgery with intraocular lens implantation. J Cataract
2008; 25:979994 Refract Surg 1997; 23:10641069
67. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. 84. Motschmann M, Behrens-Baumann W. Antiseptik in der Katar-
Fourth generation fluoroquinolones: new weapons in the arsenal aktchirurgie. Ophthalmo-Chirurgie 2000; 12:914
of ophthalmic antibiotics. Am J Ophthalmol 2002; 133:463466
68. Jensen MK, Fiscella RG, Moshirfar M, Mooney B. Third- and
fourth-generation fluoroquinolones: retrospective comparison OTHER CITED MATERIAL
of endophthalmitis after cataract surgery performed over 10 A. Behndig A. Personal communication, 2012
years. J Cataract Refract Surg 2008; 34:14601467 B. Kodjikian L. Personal communication, 2012
69. Lane SS, Osher RH, Masket S, Belani S. Evaluation of the C. Gold R, Practice Styles and Preferences of French Cataract
safety of prophylactic intracameral moxifloxacin in cataract sur- and Refractive Surgeons: 2011-2012 Survey, poster pre-
gery. J Cataract Refract Surg 2008; 34:14511459 sented at the XXX congress of the European Society of Cata-
70. Arbisser LB. Safety of intracameral moxifloxacin for prophy- ract & Refractive Surgeons, Milan, Italy, September 2012
laxis of endophthalmitis after cataract surgery. J Cataract D. Chapman J. Thousands could lose their sight as NHS cuts
Refract Surg 2008; 34:11141120 cataract surgery by a quarter. MailOnline (Health). Last update
71. Romano A, Mayorga C, Torres MJ, Artesani MC, Suau R, 16 July 2012. Available at: at http://www.dailymail.co.
Sanchez F, Pe rez E, Venuti A, Blanca M. Immediate allergic uk/health/article-2174056/Thousands-lose-sight-NHS-cuts-
reactions to cephalosporins: cross-reactivity and selective cataract-surgery-quarter.html. Accessed March 7, 2013
responses. J Allergy Clin Immunol 2000; 106:11771183. E. Gu ell JL. Personal communication, 2012
Available at: http://www.carloshaya.net/biblioteca/contenidos/ F. Pleyer U. Personal communication, 2012
home/produccion/jaci1.pdf. Accessed March 7, 2013 G. Tassignon M-J. Personal communication, 2012
72. Romano A, Gue ant-Rodriguez R-M, Viola M, Pettinato R, H. Mencucci R. Personal communication, 2012
Gue ant J-L. Cross-reactivity and tolerability of cephalosporins I. Nuijts RMMA. Personal communication, 2012
in patients with immediate hypersensitivity to penicillins. Ann J. Henry Y, Practice Styles and Preferences of Dutch Cataract
Intern Med 2004; 141:1622 and Refractive Surgeons, 2010 Survey presented at the
73. Villada JR, Vicente U, Javaloy J, Alio JL. Severe anaphylactic annual meeting of the Nederlands Oogheelkundig Gezel-
reaction after intracameral antibiotic administration during schap, Groningen, The Netherlands, March 2012
cataract surgery. J Cataract Refract Surg 2005; 31:620621 K. Szaflik JP. Personal communication, 2012